1. Introduction: Observed System Behavior In the UK pharmaceutical market, commercial discussions often begin with sales performance and market share. Yet NHS Primary Care prescribing data contains monthly signals that are not forecasts; they are observed system behavior. By the time commercial data hardens the narrative, prescribing patterns have often already evolved. The advantage lies not in reacting faster, but in recognizing change earlier. 2. Commercial Movement vs. Behavioral...

Portfolio strategy in healthcare is fundamentally different from portfolio strategy in most other industries. Decisions are not driven by short-term sales signals or commercial noise, but by long-term direct prescribing behavior, sustainability, and healthcare system dynamics . This is where Merlinn plays a distinct role. From “Is this worth exploring?” to “Is this structurally meaningful?” Portfolio teams are often asked difficult questions early in the decision process: Is demand in this...

🔷How Market Access Teams work with Merlinn Insights How do you track the real-world impact of your access decisions post-launch? Closing the gap between clinical evidence and healthcare system realities is essential — not only to secure access, but to ensure it remains sustainable over time. This visual illustrates how Market Access teams use tools like Merlinn Insights to transform NHS primary care prescribing data into strategic understanding, helping keep access decisions aligned with...